BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 12546871)

  • 1. Permeability issues in nasal drug delivery.
    Arora P; Sharma S; Garg S
    Drug Discov Today; 2002 Sep; 7(18):967-75. PubMed ID: 12546871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nasal delivery of high molecular weight drugs.
    Ozsoy Y; Gungor S; Cevher E
    Molecules; 2009 Sep; 14(9):3754-79. PubMed ID: 19783956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranasal delivery of systemic-acting drugs: small-molecules and biomacromolecules.
    Fortuna A; Alves G; Serralheiro A; Sousa J; Falcão A
    Eur J Pharm Biopharm; 2014 Sep; 88(1):8-27. PubMed ID: 24681294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative estimation of drug permeation through nasal mucosa using in vitro membrane permeability across Calu-3 cell layers for predicting in vivo bioavailability after intranasal administration to rats.
    Inoue D; Furubayashi T; Tanaka A; Sakane T; Sugano K
    Eur J Pharm Biopharm; 2020 Apr; 149():145-153. PubMed ID: 32057906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The nasal delivery of systemic drugs.
    Jones NS; Quraishi S; Mason JD
    Int J Clin Pract; 1997; 51(5):308-11. PubMed ID: 9489091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nasal route for vaccine and drug delivery: Features and current opportunities.
    Lobaina Mato Y
    Int J Pharm; 2019 Dec; 572():118813. PubMed ID: 31678521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of RPMI 2650 as a cell model to evaluate solid formulations for intranasal delivery of drugs.
    Gonçalves VSS; Matias AA; Poejo J; Serra AT; Duarte CMM
    Int J Pharm; 2016 Dec; 515(1-2):1-10. PubMed ID: 27702697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucoadhesive in situ nasal gelling drug delivery systems for modulated drug delivery.
    Singh RM; Kumar A; Pathak K
    Expert Opin Drug Deliv; 2013 Jan; 10(1):115-30. PubMed ID: 23199072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation and physiological factors influencing CNS delivery upon intranasal administration.
    Vyas TK; Tiwari SB; Amiji MM
    Crit Rev Ther Drug Carrier Syst; 2006; 23(4):319-47. PubMed ID: 17341201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In situ gel-forming system: an attractive alternative for nasal drug delivery.
    Wang X; Liu G; Ma J; Guo S; Gao L; Jia Y; Li X; Zhang Q
    Crit Rev Ther Drug Carrier Syst; 2013; 30(5):411-34. PubMed ID: 24099327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-metabolizing Enzymes and Efflux Transporters in Nasal Epithelium: Influence on the Bioavailability of Intranasally Administered Drugs.
    Oliveira P; Fortuna A; Alves G; Falcao A
    Curr Drug Metab; 2016; 17(7):628-47. PubMed ID: 27048181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanosized Drug Delivery Systems for Direct Nose to Brain Targeting: A Review.
    Phukan K; Nandy M; Sharma RB; Sharma HK
    Recent Pat Drug Deliv Formul; 2016; 10(2):156-64. PubMed ID: 26996366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal Drug Delivery: A Non-Invasive Approach for the Better Delivery of Neurotherapeutics.
    Kumar H; Mishra G; Sharma AK; Gothwal A; Kesharwani P; Gupta U
    Pharm Nanotechnol; 2017; 5(3):203-214. PubMed ID: 28521670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absorption enhancers for nasal drug delivery.
    Davis SS; Illum L
    Clin Pharmacokinet; 2003; 42(13):1107-28. PubMed ID: 14531723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors affecting nasal drug delivery and design strategies for intranasal drug delivery.
    Hu X; Yue X; Wu C; Zhang X
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Jun; 52(3):328-337. PubMed ID: 37476944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranasal drug delivery: how, why and what for?
    Pires A; Fortuna A; Alves G; Falcão A
    J Pharm Pharm Sci; 2009; 12(3):288-311. PubMed ID: 20067706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms and solutions for nasal drug delivery - a narrative review.
    Ulusoy S; Bayar Muluk N; Karpischenko S; Passali GC; Negm H; Passali D; Milkov M; Kopacheva-Barsova G; Konstantinidis I; Dilber M; Cingi C
    Eur Rev Med Pharmacol Sci; 2022 Dec; 26(2 Suppl):72-81. PubMed ID: 36524914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug development of intranasally delivered peptides.
    Campbell C; Morimoto BH; Nenciu D; Fox AW
    Ther Deliv; 2012 Apr; 3(4):557-68. PubMed ID: 22834082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranasal drug delivery for systemic medications.
    Chien YW; Chang SF
    Crit Rev Ther Drug Carrier Syst; 1987; 4(2):67-194. PubMed ID: 3319200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From nose to brain: understanding transport capacity and transport rate of drugs.
    Wu H; Hu K; Jiang X
    Expert Opin Drug Deliv; 2008 Oct; 5(10):1159-68. PubMed ID: 18817519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.